FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2026/02/103952 [Registered on: 16/02/2026] Trial Registered Prospectively
Last Modified On: 13/02/2026
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   A study on participants with depression to compare the effect of Shirishadi yoga and saraswatha choorna interventions on the reduction of depression symptoms  
Scientific Title of Study   A Comparative Clinical Study To Evaluate The Efficacy Of Shirishadi Yoga And Saraswata Choorna In Vishada (Depression) 
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NI  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  S Akash 
Designation  Post graduate schoar 
Affiliation  Alvas Ayurveda Medical college and Hospital 
Address  Department of Manovijnyana evam manasaroga 1st floor alvas ayuurveda medical college and hospital vidyagiri moodubidire karnataka
alvas ayuurveda medical college and hospital vidyagiri 13 national highway puttige padavu moodubidiri
Dakshina Kannada
KARNATAKA
574227
India 
Phone  8884143438  
Fax    
Email  ayurvedadrakash@gmai.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Smitha K 
Designation  Associate Professor 
Affiliation  Alvas Ayurveda Medical college and Hospital 
Address  Department of Manovijnyana evam manasaroga 1st floor alvas ayuurveda medical college and hospital vidyagiri moodubidire karnataka
alvas ayuurveda medical college and hospital vidyagiri 13 national highway puttige padavu moodubidiri
Dakshina Kannada
KARNATAKA
574227
India 
Phone  8762309105  
Fax    
Email  dr.smithasuraj@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Smitha K 
Designation  Associate Professor 
Affiliation  Alvas Ayurveda Medical college and Hospital 
Address  Department of Manovijnyana evam manasaroga 1st floor alvas ayuurveda medical college and hospital vidyagiri moodubidire karnataka
alvas ayuurveda medical college and hospital vidyagiri 13 national highway puttige padavu moodubidiri
Dakshina Kannada
KARNATAKA
574227
India 
Phone  8762309105  
Fax    
Email  dr.smithasuraj@gmail.com  
 
Source of Monetary or Material Support  
Alvas Ayurveda Medical College And Hospital Vidyagiri Moodubidire Dakshina Kannada Karnataka India 574227 
 
Primary Sponsor  
Name  S Akash 
Address  Department of Manovijnyana evam manasaroga 1st floor alvas ayuurveda medical college and hospital vidyagiri moodubidire karnataka  
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr S Akash  Alvas Ayurveda Medical College And Hospital  Department of Manovijnyana evam manasaroga 1st floor room number 3 alvas ayuurveda medical college and hospital vidyagiri moodubidire karnataka alvas ayuurveda medica college and hospital vidyagiri 13 national highway puttige padavu moodubidiri
Dakshina Kannada
KARNATAKA 
8884143438

ayurvedadrakash@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics committee Alvas ayurveda college moodubidire karnatak  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:F320||Major depressive disorder, singleepisode, mild. Ayurveda Condition: VISHADAH/DINATA (KEVALAVATA), (2) ICD-10 Condition:F321||Major depressive disorder, singleepisode, moderate. Ayurveda Condition: VISHADAH/DINATA (KEVALAVATA),  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Comparator ArmDrugClassical(1) Medicine Name: saraswatha choorna, Reference: sahasra yoga choorna prakarana, Route: Oral, Dosage Form: Churna/ Powder, Dose: 3(g), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 21 Days, anupAna/sahapAna: Yes(details: -madhu and sarpi), Additional Information: -madhu and sarpi are given in unequal quantities
2Intervention ArmDrugClassical(1) Medicine Name: shirishadi yoga, Reference: yogaratnakara unmada cikistha, Route: Oral, Dosage Form: Churna/ Powder, Dose: 3(g), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 21 Days, anupAna/sahapAna: Yes(details: -madhu and sarpi), Additional Information: -madhu and sarpi given in unequal quantities
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  patients wiling to participate and give informed written consent 
 
ExclusionCriteria 
Details  1 severe depression and other psychiatric disorders
2 current use of anti psychiatric drugs or undergoing psychiatric therapy
3 pregnant and lactating women 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
to evaluate the efficacy of shirishadi yoga in comparison to saraswatha choorna in the management of vishada (depression)  base line day,11 th day, 21 th day, 31 day 
 
Secondary Outcome  
Outcome  TimePoints 
nil  nil 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   27/02/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   According to WHO 2022 report depression effects over 280 million worldwide making it one of most prevalent mental health conditions in most of the depression cases anti depressants and moos stabilizers are prescribed for management which have varying degree of drug interactions in such scenario there is need for efficient management in safer way there shirishadi yoga is proposed for clinical evaluation to assess it effectiveness   
Close